Table 3.
Receipt of HIV and TB Monitoring Services After Treatment Initiation Among Eligible Participants
| Total | Pretraining | Posttraining | ||
|---|---|---|---|---|
| Services Received | n (%) | n (%) | n (%) | P a |
| A. ART CHART REVIEWS | ||||
| Receipt of an HIV viral load test 4–8 months after ART initiation (N = 1819)b | ||||
| Yes | 661 (36.3) | 356 (37.0) | 305 (35.6) | .678 |
| No | 1158 (63.7) | 607 (63.0) | 551 (64.4) | |
| Among those on a tenofovir-based regimen, receipt of a creatinine clearance test 5–7 months after ART initiation (N = 1765) | ||||
| Yes | 352 (19.9) | 166 (17.6) | 186 (22.6) | .089 |
| No | 1413 (80.1) | 777 (82.4) | 636 (77.4) | |
| B. TB CHART REVIEWS | ||||
| Initial TB test documented at diagnosis (N = 2071) | ||||
| Yes | 1818 (87.8) | 911 (85.7) | 907 (90.0) | .011 |
| No | 253 (12.2) | 152 (14.3) | 101 (10.0) | |
| Initial TB test documented positive at diagnosis (N = 1818)c | ||||
| Yes | 1394 (76.7) | 629 (69.0) | 765 (84.3) | <.001 |
| No | 424 (23.3) | 282 (31.0) | 142 (15.7) | |
| End of intensive phase TB test documented 1–4 months after TB treatment initiation (N = 2006)d | ||||
| Yes | 1418 (70.7) | 726 (70.3) | 692 (71.0) | .810 |
| No | 588 (29.3) | 306 (29.7) | 282 (29.0) | |
| If end of intensive phase TB was positive, additional TB test documented 0.5–1.5 months later (N = 167) | ||||
| Yes | 65 (38.9) | 25 (32.9) | 40 (44.0) | .185 |
| No | 102 (61.1) | 51 (67.1) | 51 (56.0) | |
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; TB, tuberculosis.
a χ 2 test adjusting for clustering at the facility level. Statistically significant differences pre- and posttraining (p < .05) are labeled in bold.
bExcludes 303 patients (111 pretraining [10.3%] and 192 posttraining [18.3%]) who were not in ART treatment during the 6-month monitoring period due to death, transfer to another facility, treatment default, or lost to follow-up.
cExcludes 253 patients with no documentation of a TB test at diagnosis.
dExcludes 65 patients (31 pretraining [2.9%] and 34 posttraining [3.4%]) who were not in TB treatment at the end of the intensive phase due to death, transfer to another facility, treatment default, or lost to follow-up.